• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经营养素-2 在神经元损伤期间的上调介导了一种对多巴胺能神经元变性的补偿性保护反应。

Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration.

机构信息

Parkinson Disorders Research Program, Iowa Center for Advanced Neurotoxicology, Department of Biomedical Sciences, Iowa State University, Ames, Iowa 50011, USA.

School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.

出版信息

Nat Commun. 2016 Oct 5;7:12932. doi: 10.1038/ncomms12932.

DOI:10.1038/ncomms12932
PMID:27703142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5059486/
Abstract

Prokineticin-2 (PK2), a recently discovered secreted protein, regulates important physiological functions including olfactory biogenesis and circadian rhythms in the CNS. Interestingly, although PK2 expression is low in the nigral system, its receptors are constitutively expressed on nigrostriatal neurons. Herein, we demonstrate that PK2 expression is highly induced in nigral dopaminergic neurons during early stages of degeneration in multiple models of Parkinson's disease (PD), including PK2 reporter mice and MitoPark mice. Functional studies demonstrate that PK2 promotes mitochondrial biogenesis and activates ERK and Akt survival signalling pathways, thereby driving neuroprotection. Importantly, PK2 overexpression is protective whereas PK2 receptor antagonism exacerbates dopaminergic degeneration in experimental PD. Furthermore, PK2 expression increased in surviving nigral dopaminergic neurons from PD brains, indicating that PK2 upregulation is clinically relevant to human PD. Collectively, our results identify a paradigm for compensatory neuroprotective PK2 signalling in nigral dopaminergic neurons that could have important therapeutic implications for PD.

摘要

胃动素-2(PK2)是一种最近发现的分泌蛋白,可调节包括嗅觉发生和中枢神经系统昼夜节律在内的重要生理功能。有趣的是,尽管 PK2 在黑质系统中的表达水平较低,但它的受体在黑质纹状体神经元中持续表达。在此,我们证明,在包括 PK2 报告小鼠和 MitoPark 小鼠在内的多种帕金森病(PD)模型的早期退行性变过程中,PK2 在黑质多巴胺能神经元中高度诱导表达。功能研究表明,PK2 促进线粒体生物发生,并激活 ERK 和 Akt 存活信号通路,从而驱动神经保护。重要的是,PK2 的过表达具有保护作用,而 PK2 受体拮抗作用则加剧了实验性 PD 中的多巴胺能变性。此外,PD 大脑中存活的黑质多巴胺能神经元中的 PK2 表达增加,表明 PK2 的上调与人类 PD 具有临床相关性。总之,我们的研究结果确定了一种在黑质多巴胺能神经元中补偿性神经保护 PK2 信号的范例,这可能对 PD 具有重要的治疗意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/908d29ab6893/ncomms12932-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/2a20142a6596/ncomms12932-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/d1431a1cbdf7/ncomms12932-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/23bda143a95f/ncomms12932-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/e464442b2ff1/ncomms12932-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/5e0db3945364/ncomms12932-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/018309262f62/ncomms12932-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/d18e93fa4cdf/ncomms12932-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/b695d3f312c2/ncomms12932-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/c28542baa2a8/ncomms12932-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/908d29ab6893/ncomms12932-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/2a20142a6596/ncomms12932-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/d1431a1cbdf7/ncomms12932-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/23bda143a95f/ncomms12932-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/e464442b2ff1/ncomms12932-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/5e0db3945364/ncomms12932-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/018309262f62/ncomms12932-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/d18e93fa4cdf/ncomms12932-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/b695d3f312c2/ncomms12932-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/c28542baa2a8/ncomms12932-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e4/5059486/908d29ab6893/ncomms12932-f10.jpg

相似文献

1
Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration.神经营养素-2 在神经元损伤期间的上调介导了一种对多巴胺能神经元变性的补偿性保护反应。
Nat Commun. 2016 Oct 5;7:12932. doi: 10.1038/ncomms12932.
2
Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes.促动力素 2 促进星形胶质细胞的趋化性和 A2 活性的替代。
Glia. 2018 Oct;66(10):2137-2157. doi: 10.1002/glia.23467. Epub 2018 Sep 12.
3
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.线粒体 DNA 缺失在多巴胺能神经元内的积累引发神经保护机制。
Brain. 2013 Aug;136(Pt 8):2369-78. doi: 10.1093/brain/awt196.
4
Regulation of prokineticin 2 expression by light and the circadian clock.光和生物钟对促动力蛋白2表达的调控。
BMC Neurosci. 2005 Mar 11;6:17. doi: 10.1186/1471-2202-6-17.
5
Disruption of the circadian output molecule prokineticin 2 results in anxiolytic and antidepressant-like effects in mice.昼夜节律输出分子促胃动素2的破坏导致小鼠产生抗焦虑和抗抑郁样效应。
Neuropsychopharmacology. 2009 Jan;34(2):367-73. doi: 10.1038/npp.2008.61. Epub 2008 Apr 23.
6
Prokineticin 2 modulates the excitability of area postrema neurons in vitro in the rat.胃动素 2 在体外调节大鼠孤束核神经元的兴奋性。
Am J Physiol Regul Integr Comp Physiol. 2010 Mar;298(3):R617-26. doi: 10.1152/ajpregu.00620.2009. Epub 2010 Jan 6.
7
Prokineticin 2 Plays a Pivotal Role in Psoriasis.促动力蛋白2在银屑病中起关键作用。
EBioMedicine. 2016 Nov;13:248-261. doi: 10.1016/j.ebiom.2016.10.022. Epub 2016 Oct 19.
8
Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.小胶质细胞中蛋白激酶Cδ的上调在帕金森病实验模型中驱动神经炎症反应和多巴胺能神经变性。
Neurobiol Dis. 2016 Sep;93:96-114. doi: 10.1016/j.nbd.2016.04.008. Epub 2016 May 2.
9
Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.杨梅素改善6-羟基多巴胺诱导的小鼠脑黑质多巴胺能神经元丢失。
J Med Food. 2016 Apr;19(4):374-82. doi: 10.1089/jmf.2015.3581. Epub 2016 Mar 18.
10
Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.在帕金森病的MPTP小鼠模型中,全身给药的神经调节蛋白-1β1通过ErbB4受体酪氨酸激酶挽救黑质多巴胺能神经元。
J Neurochem. 2015 May;133(4):590-7. doi: 10.1111/jnc.13026. Epub 2015 Jan 26.

引用本文的文献

1
Research trends of piezoelectric materials in neurodegenerative disease applications.压电材料在神经退行性疾病应用中的研究趋势
Bioact Mater. 2025 Jun 13;52:366-392. doi: 10.1016/j.bioactmat.2025.06.022. eCollection 2025 Oct.
2
Mitochondrial stress-induced H4K12 hyperacetylation dysregulates transcription in Parkinson's disease.线粒体应激诱导的H4K12高乙酰化失调帕金森病中的转录。
Front Cell Neurosci. 2024 Aug 12;18:1422362. doi: 10.3389/fncel.2024.1422362. eCollection 2024.
3
Targeting JAK2/STAT3, NLRP3/Caspase-1, and PK2/PKR2 Pathways with Arbutin Ameliorates Lead Acetate-Induced Testicular Injury in Rats.

本文引用的文献

1
The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemia.沉默调节蛋白2抑制剂AK7在帕金森病模型中具有神经保护作用,但在肌萎缩侧索硬化症和脑缺血模型中则不然。
PLoS One. 2015 Jan 21;10(1):e0116919. doi: 10.1371/journal.pone.0116919. eCollection 2015.
2
Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.新型对苯基取代二吲哚甲烷在帕金森病小鼠模型中可预防MPTP神经毒性并抑制神经胶质细胞激活。
Toxicol Sci. 2015 Feb;143(2):360-73. doi: 10.1093/toxsci/kfu236. Epub 2014 Nov 17.
3
熊果苷靶向JAK2/STAT3、NLRP3/半胱天冬酶-1和PK2/PKR2信号通路可改善醋酸铅诱导的大鼠睾丸损伤。
Pharmaceuticals (Basel). 2024 Jul 8;17(7):909. doi: 10.3390/ph17070909.
4
Nicotine restores olfactory function by activation of prok2R/Akt/FoxO3a axis in Parkinson's disease.尼古丁通过激活帕金森病中的 prok2R/Akt/FoxO3a 轴来恢复嗅觉功能。
J Transl Med. 2024 Apr 12;22(1):350. doi: 10.1186/s12967-024-05171-1.
5
MRAP2 Inhibits β-Arrestin-2 Recruitment to the Prokineticin Receptor 2.MRAP2抑制β-抑制蛋白2募集至前动力蛋白受体2。
Curr Issues Mol Biol. 2024 Feb 17;46(2):1607-1620. doi: 10.3390/cimb46020104.
6
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.靶向促动力素受体在疾病中的治疗潜力。
Pharmacol Rev. 2023 Nov;75(6):1167-1199. doi: 10.1124/pharmrev.122.000801. Epub 2023 Sep 8.
7
TRIM11 protects against tauopathies and is down-regulated in Alzheimer's disease.TRIM11 可预防神经tau 病变,并在阿尔茨海默病中下调。
Science. 2023 Jul 28;381(6656):eadd6696. doi: 10.1126/science.add6696.
8
Identification of gene polymorphisms as predictors of methamphetamine use disorder risk and indicators of craving scale in the Chinese Han population.在中国汉族人群中鉴定基因多态性作为甲基苯丙胺使用障碍风险的预测指标及渴求量表的指标。
Front Pharmacol. 2023 Jul 6;14:1217382. doi: 10.3389/fphar.2023.1217382. eCollection 2023.
9
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease.CRISPR/Cas9辅助干细胞疗法治疗帕金森病
Biomater Res. 2023 May 16;27(1):46. doi: 10.1186/s40824-023-00381-y.
10
Early alterations in the MCH system link aberrant neuronal activity and sleep disturbances in a mouse model of Alzheimer's disease.早期 MCH 系统的改变与阿尔茨海默病小鼠模型中异常神经元活动和睡眠障碍有关。
Nat Neurosci. 2023 Jun;26(6):1021-1031. doi: 10.1038/s41593-023-01325-4. Epub 2023 May 15.
Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity.
α-突触核蛋白毒性斑马鱼模型中的轴突退化与PGC-1α介导的保护作用
Dis Model Mech. 2014 May;7(5):571-82. doi: 10.1242/dmm.013185. Epub 2014 Mar 13.
4
Role of proteolytic activation of protein kinase Cδ in the pathogenesis of prion disease.蛋白激酶Cδ的蛋白水解激活在朊病毒病发病机制中的作用。
Prion. 2014 Jan-Feb;8(1):143-53. doi: 10.4161/pri.28369.
5
Vanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicity.钒暴露在金属神经毒性动物模型中诱发嗅觉功能障碍。
Neurotoxicology. 2014 Jul;43:73-81. doi: 10.1016/j.neuro.2013.12.004. Epub 2013 Dec 18.
6
The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.肽基脯氨酰顺反异构酶 Pin1 的上调和多巴胺能神经元中的促凋亡功能:与帕金森病发病机制的相关性。
J Biol Chem. 2013 Jul 26;288(30):21955-71. doi: 10.1074/jbc.M112.444224. Epub 2013 Jun 10.
7
G-protein-coupled receptor agonist BV8/prokineticin-2 and STAT3 protein form a feed-forward loop in both normal and malignant myeloid cells.G 蛋白偶联受体激动剂 BV8/促动力素-2 和 STAT3 蛋白在正常和恶性髓系细胞中形成正反馈回路。
J Biol Chem. 2013 May 10;288(19):13842-9. doi: 10.1074/jbc.M113.450049. Epub 2013 Apr 2.
8
A PK2/Bv8/PROK2 antagonist suppresses tumorigenic processes by inhibiting angiogenesis in glioma and blocking myeloid cell infiltration in pancreatic cancer.PK2/Bv8/PROK2 拮抗剂通过抑制神经胶质瘤中的血管生成和阻断胰腺癌中的髓样细胞浸润来抑制致瘤过程。
PLoS One. 2013;8(1):e54916. doi: 10.1371/journal.pone.0054916. Epub 2013 Jan 23.
9
MPTP mouse models of Parkinson's disease: an update.MPTP 帕金森病小鼠模型:更新。
J Parkinsons Dis. 2011;1(1):19-33. doi: 10.3233/JPD-2011-11023.
10
Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.在帕金森病的临床前模型中,一种具有口服活性的夹竹桃麻素衍生物的抗炎和神经保护作用。
J Neuroinflammation. 2012 Oct 23;9:241. doi: 10.1186/1742-2094-9-241.